Davis Polk advised iKang Guobin Healthcare Group, Inc. in connection with its issuance and sale of convertible redeemable series F preferred shares to Goldman Sachs (GS) and Government of Singapore Investment Corporation (GIC). GS and GIC’s total investment amount was approximately US$100 million.
iKang is a leading provider in China’s private preventive healthcare services market and is engaged in the business of providing health examination, outpatient, dental and healthcare management services to customers in the PRC.
The Davis Polk corporate team included partners Howard Zhang and Li He. Partner John D. Paton and counsel Alon Gurfinkel provided tax advice. Counsel Jeanine P. McGuinness provided OFAC advice. Xu Zheng and Siyuan Wang were the legal assistants on the transaction. Members of the Davis Polk team are based in the Beijing, London and Washington DC offices.
